Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome Academic Article uri icon

Overview

MeSH Major

  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • This is the largest conservatively treated prostate cancer cohort with long-term follow-up and contemporary assessment of grade. It validates the formation of five grade groups and suggests that the 'worst' grade is a valid prognostic measure.

publication date

  • May 10, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4865975

Digital Object Identifier (DOI)

  • 10.1038/bjc.2016.86

PubMed ID

  • 27100731

Additional Document Info

start page

  • 1078

end page

  • 83

volume

  • 114

number

  • 10